fda approval semaglutide mash The just approved (specifically under the brand Wegovy who submitted the research for approval), for the treatment of Non-Alcoholic Fatty Liver Disease, specifically Metabolic E✨ Breaking News: FDA Grants

Regular blood glucose monitoring and gradual dose titration can help minimise side effects and identify underlying causes of sweating

Semaglutide is prescribed to people with : Type 2 diabetes that isnt adequately controlled with diet and exercise alone A body mass index (BMI) of 30 or higher (classified as obesity ) A BMI of 27 or higher (classified as overweight) and a weight-related health condition such as diabetes, high blood pressure, or heart disease If you fall into one or more of the above categories, your healthcare provider may recommend semaglutide as a treatment option

Improves Blood Sugar Regulation: Helps stabilize glucose and insulin response for better metabolic efficiency

The FDA issued a similar warning in December 2023 when thousands of counterfeit Ozempic units were seized, some of which are believed to still be circulating

Read those numbers again